CA Stock MarketDetailed Quotes

ORIG Origin Therapeutics Holdings Inc

Watchlist
  • 0.025
  • 0.0000.00%
15min DelayTrading Oct 2 16:00 ET
1.41MMarket Cap-500P/E (TTM)

Origin Therapeutics Holdings Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
(Q2)Mar 31, 2022
(FY)Sep 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
-47.35%3.07M
-48.81%3.33M
--5.06M
-21.74%5.23M
--5.23M
--5.82M
--6.5M
--6.68M
-Cash and cash equivalents
-22.59%2.56M
-26.84%2.82M
--2.9M
-32.93%3.04M
--3.04M
--3.31M
--3.86M
--4.54M
-Accounts receivable
--71.32K
--42.77K
--14.72K
----
----
----
----
----
-Other receivables
-20.46%60.15K
-20.46%60.15K
--60.15K
0.00%75.63K
--75.63K
--75.63K
--75.63K
--75.63K
Total current assets
-48.35%3.19M
-49.00%3.37M
--5.13M
-21.19%5.31M
--5.31M
--6.18M
--6.61M
--6.74M
Non current assets
Regulatory assets
-75.82%71.32K
106.85%42.77K
--64.09K
810.19%52.07K
--52.07K
--294.99K
--20.68K
--5.72K
Total assets
----
----
----
--0
--0
--36.58K
--17.98K
--3.02K
Liabilities
Current liabilities
-accounts payable
-59.84%49.71K
-25.11%163.74K
--44.55K
-19.90%83.7K
--83.7K
--123.77K
--218.64K
--104.5K
-Total tax payable
--0
--0
--0
--0
--0
--0
--0
--0
Current liabilities
-44.91%109.86K
-23.92%223.89K
--104.7K
-11.55%159.32K
--159.32K
--199.4K
--294.27K
--180.12K
Non current liabilities
Total non current liabilities
-44.91%109.86K
-23.92%223.89K
--104.7K
-11.55%159.32K
--159.32K
--199.4K
--294.27K
--180.12K
Shareholders'equity
Share capital
0.00%6.96M
0.00%6.96M
--6.96M
0.00%6.96M
--6.96M
--6.96M
--6.96M
--6.96M
-common stock
0.00%6.96M
0.00%6.96M
--6.96M
0.00%6.96M
--6.96M
--6.96M
--6.96M
--6.96M
Gains losses not affecting retained earnings
0.00%769K
-49.06%391.7K
--769K
0.00%769K
--769K
--769K
--769K
--769K
Total equity
-48.35%3.19M
-49.00%3.37M
--5.4M
-20.83%5.59M
--5.59M
--6.18M
--6.61M
--7.06M
(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022(Q2)Mar 31, 2022(FY)Sep 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments -47.35%3.07M-48.81%3.33M--5.06M-21.74%5.23M--5.23M--5.82M--6.5M--6.68M
-Cash and cash equivalents -22.59%2.56M-26.84%2.82M--2.9M-32.93%3.04M--3.04M--3.31M--3.86M--4.54M
-Accounts receivable --71.32K--42.77K--14.72K--------------------
-Other receivables -20.46%60.15K-20.46%60.15K--60.15K0.00%75.63K--75.63K--75.63K--75.63K--75.63K
Total current assets -48.35%3.19M-49.00%3.37M--5.13M-21.19%5.31M--5.31M--6.18M--6.61M--6.74M
Non current assets
Regulatory assets -75.82%71.32K106.85%42.77K--64.09K810.19%52.07K--52.07K--294.99K--20.68K--5.72K
Total assets --------------0--0--36.58K--17.98K--3.02K
Liabilities
Current liabilities
-accounts payable -59.84%49.71K-25.11%163.74K--44.55K-19.90%83.7K--83.7K--123.77K--218.64K--104.5K
-Total tax payable --0--0--0--0--0--0--0--0
Current liabilities -44.91%109.86K-23.92%223.89K--104.7K-11.55%159.32K--159.32K--199.4K--294.27K--180.12K
Non current liabilities
Total non current liabilities -44.91%109.86K-23.92%223.89K--104.7K-11.55%159.32K--159.32K--199.4K--294.27K--180.12K
Shareholders'equity
Share capital 0.00%6.96M0.00%6.96M--6.96M0.00%6.96M--6.96M--6.96M--6.96M--6.96M
-common stock 0.00%6.96M0.00%6.96M--6.96M0.00%6.96M--6.96M--6.96M--6.96M--6.96M
Gains losses not affecting retained earnings 0.00%769K-49.06%391.7K--769K0.00%769K--769K--769K--769K--769K
Total equity -48.35%3.19M-49.00%3.37M--5.4M-20.83%5.59M--5.59M--6.18M--6.61M--7.06M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data